GW Pharma CEO: It's 'important to distinguish between what's medicine and what's not' in cannabis
November 01, 2018 at 18:31 PM EDT
Jim Cramer hears from GW Pharmaceuticals CEO Justin Gover about his company's cannabis-based epilepsy treatment that just launched in the United States.
